sumatriptan has been researched along with Raynaud Disease in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
Excerpt | Relevance | Reference |
---|---|---|
"A total of 137 patients with chest pain associated with intake of sumatriptan were identified and compared with 229 consumers of sumatriptan without this adverse reaction." | 7.69 | Characteristics and determinants of sumatriptan-associated chest pain. ( Grobbee, DE; Ottervanger, JP; Stricker, BH; Valkenburg, HA, 1997) |
"A total of 137 patients with chest pain associated with intake of sumatriptan were identified and compared with 229 consumers of sumatriptan without this adverse reaction." | 3.69 | Characteristics and determinants of sumatriptan-associated chest pain. ( Grobbee, DE; Ottervanger, JP; Stricker, BH; Valkenburg, HA, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ottervanger, JP | 1 |
Valkenburg, HA | 1 |
Grobbee, DE | 1 |
Stricker, BH | 1 |
1 other study available for sumatriptan and Raynaud Disease
Article | Year |
---|---|
Characteristics and determinants of sumatriptan-associated chest pain.
Topics: Adult; Age Distribution; Chest Pain; Cohort Studies; Female; Humans; Hypertension; Male; Middle Aged | 1997 |